BN Business News
Unternehmen hinzufügen →
Diese Übersetzung wird noch vorbereitet. Bis dahin zeigen wir vorübergehend die englische Originalversion.

Geschäft · 29.10.20191 Min. Lesezeit

Medical Devices; Clinical Chemistry and Clinical Toxicology Devices; Classification of the Continuous Glucose Monitor Data Management System

Lokale automatische Übersetzung · Originalsprache der Quelle

Zusammenfassung

The Food and Drug Administration (FDA or we) is classifying the continuous glucose monitor data management system into class I (general controls). We are taking this action because we have determined that classifying the device into class I (general controls) will provide a reasonable assurance of safety and effectiveness of the device. We believe this action will also enhance patients' access to beneficial innovative devices, in part by reducing regulatory burdens.

Originalsprache der Quelle: Federal Register — Food and Drug AdministrationOriginalquelle öffnen →

Weitere Themen

Business-Analysen →